nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—Acitretin—CYP26A1—esophageal cancer	0.00881	0.285	CrCbGaD
Isotretinoin—Alitretinoin—CRABP1—esophageal cancer	0.0081	0.262	CrCbGaD
Isotretinoin—Vitamin A—CYP26A1—esophageal cancer	0.00616	0.199	CrCbGaD
Isotretinoin—Tretinoin—CRABP1—esophageal cancer	0.00571	0.185	CrCbGaD
Isotretinoin—RXRG—neck—esophageal cancer	0.00381	0.225	CbGeAlD
Isotretinoin—RARB—bronchus—esophageal cancer	0.00261	0.154	CbGeAlD
Isotretinoin—RARB—lung—esophageal cancer	0.00169	0.0995	CbGeAlD
Isotretinoin—RARG—digestive system—esophageal cancer	0.00165	0.0971	CbGeAlD
Isotretinoin—RXRB—lung—esophageal cancer	0.00155	0.0914	CbGeAlD
Isotretinoin—Tretinoin—CYP2A6—esophageal cancer	0.00138	0.0448	CrCbGaD
Isotretinoin—RARG—lung—esophageal cancer	0.00137	0.0811	CbGeAlD
Isotretinoin—RARA—lung—esophageal cancer	0.00129	0.0763	CbGeAlD
Isotretinoin—RARB—lymph node—esophageal cancer	0.00115	0.068	CbGeAlD
Isotretinoin—RARG—lymph node—esophageal cancer	0.00094	0.0555	CbGeAlD
Isotretinoin—RARA—lymph node—esophageal cancer	0.000884	0.0522	CbGeAlD
Isotretinoin—Bladder pain—Methotrexate—esophageal cancer	0.000829	0.00163	CcSEcCtD
Isotretinoin—Mouth ulceration—Methotrexate—esophageal cancer	0.000829	0.00163	CcSEcCtD
Isotretinoin—Urinary tract disorder—Cisplatin—esophageal cancer	0.000829	0.00163	CcSEcCtD
Isotretinoin—Urethral disorder—Cisplatin—esophageal cancer	0.000823	0.00162	CcSEcCtD
Isotretinoin—Dry skin—Capecitabine—esophageal cancer	0.00082	0.00162	CcSEcCtD
Isotretinoin—Pulmonary oedema—Methotrexate—esophageal cancer	0.000816	0.00161	CcSEcCtD
Isotretinoin—Visual impairment—Cisplatin—esophageal cancer	0.000809	0.00159	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000805	0.00159	CcSEcCtD
Isotretinoin—Nasopharyngitis—Capecitabine—esophageal cancer	0.0008	0.00158	CcSEcCtD
Isotretinoin—Sepsis—Methotrexate—esophageal cancer	0.000796	0.00157	CcSEcCtD
Isotretinoin—Gastritis—Capecitabine—esophageal cancer	0.000792	0.00156	CcSEcCtD
Isotretinoin—Eye disorder—Cisplatin—esophageal cancer	0.000784	0.00155	CcSEcCtD
Isotretinoin—Tinnitus—Cisplatin—esophageal cancer	0.000783	0.00154	CcSEcCtD
Isotretinoin—Lymphadenopathy—Methotrexate—esophageal cancer	0.00078	0.00154	CcSEcCtD
Isotretinoin—Flushing—Cisplatin—esophageal cancer	0.000779	0.00153	CcSEcCtD
Isotretinoin—Abdominal distension—Capecitabine—esophageal cancer	0.000778	0.00153	CcSEcCtD
Isotretinoin—Dysphagia—Capecitabine—esophageal cancer	0.000773	0.00152	CcSEcCtD
Isotretinoin—Asthma—Capecitabine—esophageal cancer	0.000773	0.00152	CcSEcCtD
Isotretinoin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000765	0.00151	CcSEcCtD
Isotretinoin—Bronchospasm—Capecitabine—esophageal cancer	0.00076	0.0015	CcSEcCtD
Isotretinoin—Photosensitivity—Methotrexate—esophageal cancer	0.000758	0.00149	CcSEcCtD
Isotretinoin—Sweating increased—Capecitabine—esophageal cancer	0.000753	0.00148	CcSEcCtD
Isotretinoin—Arrhythmia—Cisplatin—esophageal cancer	0.00075	0.00148	CcSEcCtD
Isotretinoin—Alopecia—Cisplatin—esophageal cancer	0.000742	0.00146	CcSEcCtD
Isotretinoin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000741	0.00146	CcSEcCtD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—CREBBP—esophageal cancer	0.000737	0.00166	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CREBBP—esophageal cancer	0.000737	0.00166	CbGpPWpGaD
Isotretinoin—Alitretinoin—ABCB1—esophageal cancer	0.000732	0.0237	CrCbGaD
Isotretinoin—RXRG—Adipogenesis—RB1—esophageal cancer	0.000731	0.00164	CbGpPWpGaD
Isotretinoin—Erythema—Cisplatin—esophageal cancer	0.000731	0.00144	CcSEcCtD
Isotretinoin—Malnutrition—Cisplatin—esophageal cancer	0.000731	0.00144	CcSEcCtD
Isotretinoin—RXRA—Mitochondrial biogenesis—CREBBP—esophageal cancer	0.000726	0.00163	CbGpPWpGaD
Isotretinoin—Dysuria—Capecitabine—esophageal cancer	0.000723	0.00142	CcSEcCtD
Isotretinoin—Neutropenia—Capecitabine—esophageal cancer	0.000723	0.00142	CcSEcCtD
Isotretinoin—Renal failure acute—Methotrexate—esophageal cancer	0.000721	0.00142	CcSEcCtD
Isotretinoin—Flatulence—Cisplatin—esophageal cancer	0.00072	0.00142	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000718	0.00142	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000718	0.00162	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—CREBBP—esophageal cancer	0.000716	0.00161	CbGpPWpGaD
Isotretinoin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000706	0.00139	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000706	0.00139	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—esophageal cancer	0.000704	0.00158	CbGpPWpGaD
Isotretinoin—Weight increased—Capecitabine—esophageal cancer	0.000703	0.00139	CcSEcCtD
Isotretinoin—Visual disturbance—Methotrexate—esophageal cancer	0.000703	0.00138	CcSEcCtD
Isotretinoin—Weight decreased—Capecitabine—esophageal cancer	0.000699	0.00138	CcSEcCtD
Isotretinoin—Pneumonia—Capecitabine—esophageal cancer	0.000693	0.00137	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—ALDH2—esophageal cancer	0.000689	0.00155	CbGpPWpGaD
Isotretinoin—Infestation NOS—Capecitabine—esophageal cancer	0.000689	0.00136	CcSEcCtD
Isotretinoin—Infestation—Capecitabine—esophageal cancer	0.000689	0.00136	CcSEcCtD
Isotretinoin—Vision blurred—Cisplatin—esophageal cancer	0.000689	0.00136	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—RB1—esophageal cancer	0.000688	0.00155	CbGpPWpGaD
Isotretinoin—Depression—Capecitabine—esophageal cancer	0.000687	0.00135	CcSEcCtD
Isotretinoin—Tremor—Cisplatin—esophageal cancer	0.000685	0.00135	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000683	0.00135	CcSEcCtD
Isotretinoin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000679	0.00134	CcSEcCtD
Isotretinoin—Lethargy—Methotrexate—esophageal cancer	0.000679	0.00134	CcSEcCtD
Isotretinoin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000679	0.00134	CcSEcCtD
Isotretinoin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000678	0.00134	CcSEcCtD
Isotretinoin—Renal failure—Capecitabine—esophageal cancer	0.000678	0.00133	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000676	0.00133	CcSEcCtD
Isotretinoin—Myocardial infarction—Capecitabine—esophageal cancer	0.000676	0.00133	CcSEcCtD
Isotretinoin—Anaemia—Cisplatin—esophageal cancer	0.000675	0.00133	CcSEcCtD
Isotretinoin—Stomatitis—Capecitabine—esophageal cancer	0.000672	0.00132	CcSEcCtD
Isotretinoin—Conjunctivitis—Capecitabine—esophageal cancer	0.00067	0.00132	CcSEcCtD
Isotretinoin—Urinary tract infection—Capecitabine—esophageal cancer	0.00067	0.00132	CcSEcCtD
Isotretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—esophageal cancer	0.000669	0.00151	CbGpPWpGaD
Isotretinoin—Osteoarthritis—Methotrexate—esophageal cancer	0.000666	0.00131	CcSEcCtD
Isotretinoin—Malaise—Cisplatin—esophageal cancer	0.000659	0.0013	CcSEcCtD
Isotretinoin—Haematuria—Capecitabine—esophageal cancer	0.000657	0.00129	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—GSTT1—esophageal cancer	0.000656	0.00147	CbGpPWpGaD
Isotretinoin—Epistaxis—Capecitabine—esophageal cancer	0.00065	0.00128	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—CYP2A6—esophageal cancer	0.000648	0.00146	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Capecitabine—esophageal cancer	0.000643	0.00127	CcSEcCtD
Isotretinoin—Irritability—Methotrexate—esophageal cancer	0.000635	0.00125	CcSEcCtD
Isotretinoin—Convulsion—Cisplatin—esophageal cancer	0.000633	0.00125	CcSEcCtD
Isotretinoin—Mood swings—Methotrexate—esophageal cancer	0.000631	0.00124	CcSEcCtD
Isotretinoin—Myalgia—Cisplatin—esophageal cancer	0.000622	0.00123	CcSEcCtD
Isotretinoin—Haemoglobin—Capecitabine—esophageal cancer	0.000622	0.00123	CcSEcCtD
Isotretinoin—Anxiety—Cisplatin—esophageal cancer	0.00062	0.00122	CcSEcCtD
Isotretinoin—Hepatitis—Capecitabine—esophageal cancer	0.000619	0.00122	CcSEcCtD
Isotretinoin—Haemorrhage—Capecitabine—esophageal cancer	0.000619	0.00122	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000618	0.00122	CcSEcCtD
Isotretinoin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000616	0.00121	CcSEcCtD
Isotretinoin—Discomfort—Cisplatin—esophageal cancer	0.000615	0.00121	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—PTGS1—esophageal cancer	0.000614	0.00138	CbGpPWpGaD
Isotretinoin—Pharyngitis—Capecitabine—esophageal cancer	0.000614	0.00121	CcSEcCtD
Isotretinoin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000611	0.0012	CcSEcCtD
Isotretinoin—Oedema peripheral—Capecitabine—esophageal cancer	0.00061	0.0012	CcSEcCtD
Isotretinoin—Urethral disorder—Capecitabine—esophageal cancer	0.000607	0.00119	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.0006	0.00118	CcSEcCtD
Isotretinoin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000596	0.00117	CcSEcCtD
Isotretinoin—Oedema—Cisplatin—esophageal cancer	0.000596	0.00117	CcSEcCtD
Isotretinoin—Visual impairment—Capecitabine—esophageal cancer	0.000596	0.00117	CcSEcCtD
Isotretinoin—Infection—Cisplatin—esophageal cancer	0.000592	0.00117	CcSEcCtD
Isotretinoin—RARG—Gene Expression—SMG6—esophageal cancer	0.000589	0.00132	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Capecitabine—esophageal cancer	0.000585	0.00115	CcSEcCtD
Isotretinoin—Nervous system disorder—Cisplatin—esophageal cancer	0.000585	0.00115	CcSEcCtD
Isotretinoin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000584	0.00115	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000582	0.00131	CbGpPWpGaD
Isotretinoin—Tachycardia—Cisplatin—esophageal cancer	0.000582	0.00115	CcSEcCtD
Isotretinoin—Skin disorder—Cisplatin—esophageal cancer	0.000579	0.00114	CcSEcCtD
Isotretinoin—Eye disorder—Capecitabine—esophageal cancer	0.000578	0.00114	CcSEcCtD
Isotretinoin—Tinnitus—Capecitabine—esophageal cancer	0.000577	0.00114	CcSEcCtD
Isotretinoin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000576	0.00114	CcSEcCtD
Isotretinoin—Asthma—Methotrexate—esophageal cancer	0.000575	0.00113	CcSEcCtD
Isotretinoin—Flushing—Capecitabine—esophageal cancer	0.000574	0.00113	CcSEcCtD
Isotretinoin—Anorexia—Cisplatin—esophageal cancer	0.000568	0.00112	CcSEcCtD
Isotretinoin—Pancreatitis—Methotrexate—esophageal cancer	0.000564	0.00111	CcSEcCtD
Isotretinoin—Angiopathy—Capecitabine—esophageal cancer	0.000561	0.00111	CcSEcCtD
Isotretinoin—Hypotension—Cisplatin—esophageal cancer	0.000557	0.0011	CcSEcCtD
Isotretinoin—Chills—Capecitabine—esophageal cancer	0.000555	0.00109	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000554	0.00125	CbGpPWpGaD
Isotretinoin—Arrhythmia—Capecitabine—esophageal cancer	0.000553	0.00109	CcSEcCtD
Isotretinoin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000552	0.00109	CcSEcCtD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CREBBP—esophageal cancer	0.000547	0.00123	CbGpPWpGaD
Isotretinoin—Alopecia—Capecitabine—esophageal cancer	0.000547	0.00108	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000543	0.00107	CcSEcCtD
Isotretinoin—Mental disorder—Capecitabine—esophageal cancer	0.000542	0.00107	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SMG6—esophageal cancer	0.000539	0.00121	CbGpPWpGaD
Isotretinoin—Erythema—Capecitabine—esophageal cancer	0.000539	0.00106	CcSEcCtD
Isotretinoin—Malnutrition—Capecitabine—esophageal cancer	0.000539	0.00106	CcSEcCtD
Isotretinoin—Neutropenia—Methotrexate—esophageal cancer	0.000538	0.00106	CcSEcCtD
Isotretinoin—Dysuria—Methotrexate—esophageal cancer	0.000538	0.00106	CcSEcCtD
Isotretinoin—Paraesthesia—Cisplatin—esophageal cancer	0.000535	0.00105	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000535	0.00105	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000532	0.0012	CbGpPWpGaD
Isotretinoin—Dyspnoea—Cisplatin—esophageal cancer	0.000532	0.00105	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000532	0.0012	CbGpPWpGaD
Isotretinoin—Flatulence—Capecitabine—esophageal cancer	0.000531	0.00105	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000529	0.00119	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SMG6—esophageal cancer	0.000528	0.00119	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—CDKN1A—esophageal cancer	0.000525	0.00118	CbGpPWpGaD
Isotretinoin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000525	0.00103	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—CYP1B1—esophageal cancer	0.000522	0.00117	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000522	0.00117	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000522	0.00117	CbGpPWpGaD
Isotretinoin—Back pain—Capecitabine—esophageal cancer	0.000521	0.00103	CcSEcCtD
Isotretinoin—Decreased appetite—Cisplatin—esophageal cancer	0.000518	0.00102	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—TGFBR2—esophageal cancer	0.000518	0.00117	CbGpPWpGaD
Isotretinoin—Pneumonia—Methotrexate—esophageal cancer	0.000516	0.00102	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000515	0.00101	CcSEcCtD
Isotretinoin—Drowsiness—Methotrexate—esophageal cancer	0.000513	0.00101	CcSEcCtD
Isotretinoin—Infestation NOS—Methotrexate—esophageal cancer	0.000513	0.00101	CcSEcCtD
Isotretinoin—Infestation—Methotrexate—esophageal cancer	0.000513	0.00101	CcSEcCtD
Isotretinoin—Depression—Methotrexate—esophageal cancer	0.000512	0.00101	CcSEcCtD
Isotretinoin—RXRA—NRF2 pathway—HMOX1—esophageal cancer	0.000511	0.00115	CbGpPWpGaD
Isotretinoin—Pain—Cisplatin—esophageal cancer	0.00051	0.001	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00051	0.00115	CbGpPWpGaD
Isotretinoin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000509	0.001	CcSEcCtD
Isotretinoin—Vision blurred—Capecitabine—esophageal cancer	0.000508	0.001	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000507	0.00114	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.000507	0.00114	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMG6—esophageal cancer	0.000506	0.00114	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMG6—esophageal cancer	0.000506	0.00114	CbGpPWpGaD
Isotretinoin—Tremor—Capecitabine—esophageal cancer	0.000505	0.000994	CcSEcCtD
Isotretinoin—Renal failure—Methotrexate—esophageal cancer	0.000504	0.000994	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000504	0.00113	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.000502	0.00113	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000501	0.00113	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000501	0.00113	CbGpPWpGaD
Isotretinoin—Stomatitis—Methotrexate—esophageal cancer	0.0005	0.000985	CcSEcCtD
Isotretinoin—Ill-defined disorder—Capecitabine—esophageal cancer	0.0005	0.000985	CcSEcCtD
Isotretinoin—Conjunctivitis—Methotrexate—esophageal cancer	0.000499	0.000983	CcSEcCtD
Isotretinoin—Anaemia—Capecitabine—esophageal cancer	0.000498	0.000981	CcSEcCtD
Isotretinoin—RARA—Adipogenesis—CDKN1A—esophageal cancer	0.000494	0.00111	CbGpPWpGaD
Isotretinoin—Sweating—Methotrexate—esophageal cancer	0.000492	0.000969	CcSEcCtD
Isotretinoin—Feeling abnormal—Cisplatin—esophageal cancer	0.000491	0.000968	CcSEcCtD
Isotretinoin—RXRA—Biological oxidations—CYP19A1—esophageal cancer	0.000491	0.0011	CbGpPWpGaD
Isotretinoin—Haematuria—Methotrexate—esophageal cancer	0.000489	0.000964	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—esophageal cancer	0.000488	0.0011	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—EP300—esophageal cancer	0.000487	0.0011	CbGpPWpGaD
Isotretinoin—Malaise—Capecitabine—esophageal cancer	0.000486	0.000957	CcSEcCtD
Isotretinoin—Epistaxis—Methotrexate—esophageal cancer	0.000484	0.000953	CcSEcCtD
Isotretinoin—Syncope—Capecitabine—esophageal cancer	0.000483	0.000952	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000482	0.00108	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000479	0.00108	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Methotrexate—esophageal cancer	0.000479	0.000943	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000478	0.00107	CbGpPWpGaD
Isotretinoin—Palpitations—Capecitabine—esophageal cancer	0.000476	0.000938	CcSEcCtD
Isotretinoin—Loss of consciousness—Capecitabine—esophageal cancer	0.000473	0.000933	CcSEcCtD
Isotretinoin—Body temperature increased—Cisplatin—esophageal cancer	0.000471	0.000929	CcSEcCtD
Isotretinoin—Cough—Capecitabine—esophageal cancer	0.00047	0.000926	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000468	0.00105	CbGpPWpGaD
Isotretinoin—Hypertension—Capecitabine—esophageal cancer	0.000465	0.000916	CcSEcCtD
Isotretinoin—Haemoglobin—Methotrexate—esophageal cancer	0.000463	0.000912	CcSEcCtD
Isotretinoin—Hepatitis—Methotrexate—esophageal cancer	0.000461	0.000907	CcSEcCtD
Isotretinoin—Haemorrhage—Methotrexate—esophageal cancer	0.000461	0.000907	CcSEcCtD
Isotretinoin—Chest pain—Capecitabine—esophageal cancer	0.000459	0.000903	CcSEcCtD
Isotretinoin—Arthralgia—Capecitabine—esophageal cancer	0.000459	0.000903	CcSEcCtD
Isotretinoin—Myalgia—Capecitabine—esophageal cancer	0.000459	0.000903	CcSEcCtD
Isotretinoin—Pharyngitis—Methotrexate—esophageal cancer	0.000457	0.000901	CcSEcCtD
Isotretinoin—Anxiety—Capecitabine—esophageal cancer	0.000457	0.0009	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000456	0.00103	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000455	0.000897	CcSEcCtD
Isotretinoin—Urinary tract disorder—Methotrexate—esophageal cancer	0.000455	0.000896	CcSEcCtD
Isotretinoin—Discomfort—Capecitabine—esophageal cancer	0.000453	0.000893	CcSEcCtD
Isotretinoin—Urethral disorder—Methotrexate—esophageal cancer	0.000452	0.00089	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.00045	0.00101	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000449	0.00101	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000449	0.00101	CbGpPWpGaD
Isotretinoin—Dry mouth—Capecitabine—esophageal cancer	0.000448	0.000884	CcSEcCtD
Isotretinoin—RARG—Gene Expression—NR1I2—esophageal cancer	0.000446	0.001	CbGpPWpGaD
Isotretinoin—Visual impairment—Methotrexate—esophageal cancer	0.000444	0.000874	CcSEcCtD
Isotretinoin—Confusional state—Capecitabine—esophageal cancer	0.000443	0.000873	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000443	0.000997	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—HIF1A—esophageal cancer	0.00044	0.00099	CbGpPWpGaD
Isotretinoin—Oedema—Capecitabine—esophageal cancer	0.00044	0.000866	CcSEcCtD
Isotretinoin—Hypersensitivity—Cisplatin—esophageal cancer	0.000439	0.000866	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000438	0.000986	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000437	0.000984	CbGpPWpGaD
Isotretinoin—Infection—Capecitabine—esophageal cancer	0.000437	0.00086	CcSEcCtD
Isotretinoin—Erythema multiforme—Methotrexate—esophageal cancer	0.000436	0.000858	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000433	0.000975	CbGpPWpGaD
Isotretinoin—Shock—Capecitabine—esophageal cancer	0.000432	0.000852	CcSEcCtD
Isotretinoin—Nervous system disorder—Capecitabine—esophageal cancer	0.000431	0.000849	CcSEcCtD
Isotretinoin—Eye disorder—Methotrexate—esophageal cancer	0.00043	0.000848	CcSEcCtD
Isotretinoin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00043	0.000848	CcSEcCtD
Isotretinoin—RXRA—Orphan transporters—CREBBP—esophageal cancer	0.00043	0.000967	CbGpPWpGaD
Isotretinoin—Tinnitus—Methotrexate—esophageal cancer	0.000429	0.000846	CcSEcCtD
Isotretinoin—Tachycardia—Capecitabine—esophageal cancer	0.000429	0.000845	CcSEcCtD
Isotretinoin—Asthenia—Cisplatin—esophageal cancer	0.000428	0.000843	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000427	0.00096	CbGpPWpGaD
Isotretinoin—Skin disorder—Capecitabine—esophageal cancer	0.000427	0.000841	CcSEcCtD
Isotretinoin—Hyperhidrosis—Capecitabine—esophageal cancer	0.000425	0.000837	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000425	0.000956	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—esophageal cancer	0.000423	0.000952	CbGpPWpGaD
Isotretinoin—Anorexia—Capecitabine—esophageal cancer	0.000419	0.000826	CcSEcCtD
Isotretinoin—Angiopathy—Methotrexate—esophageal cancer	0.000418	0.000823	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000415	0.000935	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000415	0.000934	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PFN1—esophageal cancer	0.000414	0.000931	CbGpPWpGaD
Isotretinoin—Chills—Methotrexate—esophageal cancer	0.000413	0.000814	CcSEcCtD
Isotretinoin—RXRA—PPARA activates gene expression—CREBBP—esophageal cancer	0.000411	0.000925	CbGpPWpGaD
Isotretinoin—Hypotension—Capecitabine—esophageal cancer	0.000411	0.000809	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000408	0.000919	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NR1I2—esophageal cancer	0.000408	0.000918	CbGpPWpGaD
Isotretinoin—Diarrhoea—Cisplatin—esophageal cancer	0.000408	0.000804	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000407	0.000916	CbGpPWpGaD
Isotretinoin—Alopecia—Methotrexate—esophageal cancer	0.000407	0.000802	CcSEcCtD
Isotretinoin—Mental disorder—Methotrexate—esophageal cancer	0.000404	0.000795	CcSEcCtD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—esophageal cancer	0.000402	0.000905	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000401	0.000902	CbGpPWpGaD
Isotretinoin—Erythema—Methotrexate—esophageal cancer	0.000401	0.00079	CcSEcCtD
Isotretinoin—Malnutrition—Methotrexate—esophageal cancer	0.000401	0.00079	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0004	0.000789	CcSEcCtD
Isotretinoin—RARB—Gene Expression—NR1I2—esophageal cancer	0.0004	0.0009	CbGpPWpGaD
Isotretinoin—Insomnia—Capecitabine—esophageal cancer	0.000398	0.000783	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000396	0.00089	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000396	0.00089	CbGpPWpGaD
Isotretinoin—Paraesthesia—Capecitabine—esophageal cancer	0.000395	0.000778	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000393	0.000885	CbGpPWpGaD
Isotretinoin—Dyspnoea—Capecitabine—esophageal cancer	0.000392	0.000772	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000391	0.000881	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000391	0.000878	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000391	0.000878	CbGpPWpGaD
Isotretinoin—Back pain—Methotrexate—esophageal cancer	0.000388	0.000764	CcSEcCtD
Isotretinoin—Dyspepsia—Capecitabine—esophageal cancer	0.000387	0.000762	CcSEcCtD
Isotretinoin—RARA—Gene Expression—NR1I2—esophageal cancer	0.000384	0.000863	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NR1I2—esophageal cancer	0.000384	0.000863	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HIST1H2BM—esophageal cancer	0.000383	0.000861	CbGpPWpGaD
Isotretinoin—Decreased appetite—Capecitabine—esophageal cancer	0.000382	0.000753	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00038	0.000748	CcSEcCtD
Isotretinoin—Vomiting—Cisplatin—esophageal cancer	0.000379	0.000747	CcSEcCtD
Isotretinoin—Fatigue—Capecitabine—esophageal cancer	0.000379	0.000747	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000379	0.000852	CbGpPWpGaD
Isotretinoin—Vision blurred—Methotrexate—esophageal cancer	0.000378	0.000744	CcSEcCtD
Isotretinoin—RXRB—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000377	0.000848	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000377	0.000848	CbGpPWpGaD
Isotretinoin—Rash—Cisplatin—esophageal cancer	0.000376	0.000741	CcSEcCtD
Isotretinoin—Pain—Capecitabine—esophageal cancer	0.000376	0.000741	CcSEcCtD
Isotretinoin—Constipation—Capecitabine—esophageal cancer	0.000376	0.000741	CcSEcCtD
Isotretinoin—Dermatitis—Cisplatin—esophageal cancer	0.000376	0.00074	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000375	0.000844	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000374	0.000842	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—esophageal cancer	0.000372	0.000838	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000372	0.000733	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—esophageal cancer	0.000371	0.00073	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000363	0.000817	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Capecitabine—esophageal cancer	0.000362	0.000714	CcSEcCtD
Isotretinoin—Malaise—Methotrexate—esophageal cancer	0.000362	0.000712	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.00036	0.000811	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000359	0.000708	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—RB1—esophageal cancer	0.000358	0.000806	CbGpPWpGaD
Isotretinoin—Nausea—Cisplatin—esophageal cancer	0.000354	0.000698	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—HIST1H2BM—esophageal cancer	0.00035	0.000788	CbGpPWpGaD
Isotretinoin—Cough—Methotrexate—esophageal cancer	0.00035	0.000689	CcSEcCtD
Isotretinoin—Urticaria—Capecitabine—esophageal cancer	0.000349	0.000688	CcSEcCtD
Isotretinoin—Abdominal pain—Capecitabine—esophageal cancer	0.000348	0.000685	CcSEcCtD
Isotretinoin—Body temperature increased—Capecitabine—esophageal cancer	0.000348	0.000685	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—esophageal cancer	0.000347	0.000684	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000345	0.000777	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HIST1H2BM—esophageal cancer	0.000343	0.000773	CbGpPWpGaD
Isotretinoin—Arthralgia—Methotrexate—esophageal cancer	0.000341	0.000673	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—esophageal cancer	0.000341	0.000673	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—esophageal cancer	0.000341	0.000673	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00034	0.000766	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000339	0.000668	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—esophageal cancer	0.000337	0.000664	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CFL1—esophageal cancer	0.000335	0.000755	CbGpPWpGaD
Isotretinoin—Confusional state—Methotrexate—esophageal cancer	0.00033	0.00065	CcSEcCtD
Isotretinoin—RXRA—Organelle biogenesis and maintenance—CREBBP—esophageal cancer	0.00033	0.000741	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HIST1H2BM—esophageal cancer	0.000329	0.000741	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HIST1H2BM—esophageal cancer	0.000329	0.000741	CbGpPWpGaD
Isotretinoin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000327	0.000645	CcSEcCtD
Isotretinoin—Infection—Methotrexate—esophageal cancer	0.000325	0.00064	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SOX2—esophageal cancer	0.000324	0.000729	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Capecitabine—esophageal cancer	0.000324	0.000638	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000323	0.000727	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Methotrexate—esophageal cancer	0.000321	0.000632	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00032	0.000631	CcSEcCtD
Isotretinoin—Skin disorder—Methotrexate—esophageal cancer	0.000318	0.000626	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000316	0.000623	CcSEcCtD
Isotretinoin—Asthenia—Capecitabine—esophageal cancer	0.000315	0.000621	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000314	0.000706	CbGpPWpGaD
Isotretinoin—Anorexia—Methotrexate—esophageal cancer	0.000312	0.000615	CcSEcCtD
Isotretinoin—Pruritus—Capecitabine—esophageal cancer	0.000311	0.000613	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000307	0.000691	CbGpPWpGaD
Isotretinoin—Hypotension—Methotrexate—esophageal cancer	0.000306	0.000602	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000301	0.000677	CbGpPWpGaD
Isotretinoin—Diarrhoea—Capecitabine—esophageal cancer	0.000301	0.000593	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000298	0.000587	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PSME1—esophageal cancer	0.000297	0.000668	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—PSME2—esophageal cancer	0.000297	0.000668	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000297	0.000668	CbGpPWpGaD
Isotretinoin—Insomnia—Methotrexate—esophageal cancer	0.000296	0.000583	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000296	0.000666	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000296	0.000665	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000294	0.000662	CbGpPWpGaD
Isotretinoin—Paraesthesia—Methotrexate—esophageal cancer	0.000294	0.000579	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000293	0.000659	CbGpPWpGaD
Isotretinoin—Dyspnoea—Methotrexate—esophageal cancer	0.000292	0.000575	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—esophageal cancer	0.000291	0.000573	CcSEcCtD
Isotretinoin—Dizziness—Capecitabine—esophageal cancer	0.000291	0.000573	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.00029	0.000652	CbGpPWpGaD
Isotretinoin—Dyspepsia—Methotrexate—esophageal cancer	0.000288	0.000568	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ACTB—esophageal cancer	0.000285	0.000642	CbGpPWpGaD
Isotretinoin—Decreased appetite—Methotrexate—esophageal cancer	0.000284	0.00056	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000283	0.000557	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—esophageal cancer	0.000282	0.000556	CcSEcCtD
Isotretinoin—RARG—Gene Expression—NOTCH3—esophageal cancer	0.00028	0.00063	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CTNNA1—esophageal cancer	0.00028	0.00063	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—EP300—esophageal cancer	0.00028	0.00063	CbGpPWpGaD
Isotretinoin—Pain—Methotrexate—esophageal cancer	0.00028	0.000551	CcSEcCtD
Isotretinoin—Vomiting—Capecitabine—esophageal cancer	0.000279	0.000551	CcSEcCtD
Isotretinoin—RXRB—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000278	0.000625	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000278	0.000625	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.000277	0.000624	CbGpPWpGaD
Isotretinoin—Rash—Capecitabine—esophageal cancer	0.000277	0.000546	CcSEcCtD
Isotretinoin—Dermatitis—Capecitabine—esophageal cancer	0.000277	0.000546	CcSEcCtD
Isotretinoin—Headache—Capecitabine—esophageal cancer	0.000275	0.000543	CcSEcCtD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.000274	0.000616	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PSME2—esophageal cancer	0.000272	0.000611	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—PSME1—esophageal cancer	0.000272	0.000611	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Methotrexate—esophageal cancer	0.00027	0.000531	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000269	0.000604	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000268	0.000603	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000268	0.000527	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000267	0.0006	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PSME2—esophageal cancer	0.000266	0.000599	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PSME1—esophageal cancer	0.000266	0.000599	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000266	0.000597	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000264	0.000595	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMG6—esophageal cancer	0.000264	0.000594	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC52A3—esophageal cancer	0.000264	0.000594	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—BLVRB—esophageal cancer	0.000264	0.000594	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000263	0.000591	CbGpPWpGaD
Isotretinoin—Nausea—Capecitabine—esophageal cancer	0.000261	0.000514	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000261	0.000587	CbGpPWpGaD
Isotretinoin—Urticaria—Methotrexate—esophageal cancer	0.00026	0.000512	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—esophageal cancer	0.000259	0.00051	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—esophageal cancer	0.000259	0.00051	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000258	0.00058	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CDKN1A—esophageal cancer	0.000257	0.000579	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH3—esophageal cancer	0.000256	0.000577	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000256	0.000575	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PSME1—esophageal cancer	0.000255	0.000575	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PSME1—esophageal cancer	0.000255	0.000575	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PSME2—esophageal cancer	0.000255	0.000575	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PSME2—esophageal cancer	0.000255	0.000575	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000252	0.000567	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000252	0.000567	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH3—esophageal cancer	0.000251	0.000565	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH2—esophageal cancer	0.000251	0.000565	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000247	0.000556	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Methotrexate—esophageal cancer	0.000241	0.000475	CcSEcCtD
Isotretinoin—RARA—Gene Expression—NOTCH3—esophageal cancer	0.000241	0.000542	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH3—esophageal cancer	0.000241	0.000542	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000236	0.000531	CbGpPWpGaD
Isotretinoin—Asthenia—Methotrexate—esophageal cancer	0.000235	0.000463	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000234	0.000526	CbGpPWpGaD
Isotretinoin—Pruritus—Methotrexate—esophageal cancer	0.000232	0.000456	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—NOTCH2—esophageal cancer	0.00023	0.000517	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000228	0.000513	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH2—esophageal cancer	0.000225	0.000507	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—SLC10A2—esophageal cancer	0.000224	0.000505	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CA1—esophageal cancer	0.000224	0.000505	CbGpPWpGaD
Isotretinoin—Diarrhoea—Methotrexate—esophageal cancer	0.000224	0.000441	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000221	0.000498	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000216	0.000487	CbGpPWpGaD
Isotretinoin—Dizziness—Methotrexate—esophageal cancer	0.000216	0.000426	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—NOTCH2—esophageal cancer	0.000216	0.000486	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH2—esophageal cancer	0.000216	0.000486	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—SMAD4—esophageal cancer	0.000211	0.000475	CbGpPWpGaD
Isotretinoin—Vomiting—Methotrexate—esophageal cancer	0.000208	0.00041	CcSEcCtD
Isotretinoin—Rash—Methotrexate—esophageal cancer	0.000206	0.000406	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—esophageal cancer	0.000206	0.000406	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CA2—esophageal cancer	0.000205	0.000462	CbGpPWpGaD
Isotretinoin—Headache—Methotrexate—esophageal cancer	0.000205	0.000404	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000201	0.000451	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NR1I2—esophageal cancer	0.0002	0.00045	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000196	0.000442	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000196	0.00044	CbGpPWpGaD
Isotretinoin—Nausea—Methotrexate—esophageal cancer	0.000194	0.000383	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—SMAD4—esophageal cancer	0.000193	0.000434	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ABL1—esophageal cancer	0.000191	0.00043	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLCE1—esophageal cancer	0.000191	0.000429	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ADH7—esophageal cancer	0.000191	0.000429	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—SMAD4—esophageal cancer	0.000189	0.000426	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000189	0.000426	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.000189	0.000425	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000189	0.000424	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SMAD4—esophageal cancer	0.000185	0.000416	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—SMAD4—esophageal cancer	0.000182	0.000408	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—SMAD4—esophageal cancer	0.000182	0.000408	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.00018	0.000405	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—esophageal cancer	0.000174	0.000391	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HIST1H2BM—esophageal cancer	0.000172	0.000386	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ADH1B—esophageal cancer	0.000167	0.000376	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000164	0.000368	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMP—esophageal cancer	0.00016	0.00036	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—esophageal cancer	0.000159	0.000358	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000157	0.000353	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000157	0.000353	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—esophageal cancer	0.000156	0.000351	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH1—esophageal cancer	0.000156	0.00035	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP26A1—esophageal cancer	0.000156	0.00035	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000153	0.000345	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALOX15—esophageal cancer	0.000152	0.000341	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—esophageal cancer	0.00015	0.000336	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—esophageal cancer	0.00015	0.000336	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000145	0.000326	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KDR—esophageal cancer	0.000145	0.000326	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTO1—esophageal cancer	0.000145	0.000325	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TPI1—esophageal cancer	0.000145	0.000325	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH1—esophageal cancer	0.000142	0.00032	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MET—esophageal cancer	0.000142	0.000319	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—CREBBP—esophageal cancer	0.000141	0.000317	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH1—esophageal cancer	0.00014	0.000314	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALDOB—esophageal cancer	0.000139	0.000312	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NOTCH1—esophageal cancer	0.000136	0.000307	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH1—esophageal cancer	0.000134	0.000301	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH1—esophageal cancer	0.000134	0.000301	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GAPDH—esophageal cancer	0.000133	0.0003	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000133	0.0003	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PSME1—esophageal cancer	0.000133	0.000299	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PSME2—esophageal cancer	0.000133	0.000299	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CRABP1—esophageal cancer	0.000132	0.000297	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000131	0.000295	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—CREBBP—esophageal cancer	0.000129	0.00029	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000129	0.00029	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—CREBBP—esophageal cancer	0.000127	0.000285	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GNG7—esophageal cancer	0.000126	0.000283	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH3—esophageal cancer	0.000126	0.000283	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CREBBP—esophageal cancer	0.000124	0.000278	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CREBBP—esophageal cancer	0.000121	0.000273	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—CREBBP—esophageal cancer	0.000121	0.000273	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALDH2—esophageal cancer	0.000118	0.000265	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH2—esophageal cancer	0.000113	0.000253	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTT1—esophageal cancer	0.000112	0.000252	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2A6—esophageal cancer	0.000111	0.000249	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.00011	0.000248	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO1—esophageal cancer	0.000105	0.000236	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS1—esophageal cancer	0.000105	0.000236	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000105	0.000236	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PSME1—esophageal cancer	0.000104	0.000233	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PSME2—esophageal cancer	0.000104	0.000233	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ERBB2—esophageal cancer	0.000104	0.000233	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—SMAD4—esophageal cancer	9.46e-05	0.000213	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.04e-05	0.000203	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1B1—esophageal cancer	8.93e-05	0.000201	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EP300—esophageal cancer	8.42e-05	0.000189	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP19A1—esophageal cancer	8.4e-05	0.000189	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MYC—esophageal cancer	8.37e-05	0.000188	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—esophageal cancer	7.79e-05	0.000175	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HMOX1—esophageal cancer	7.66e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—esophageal cancer	7.66e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.52e-05	0.000169	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—esophageal cancer	7.51e-05	0.000169	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCB1—esophageal cancer	7.36e-05	0.000165	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—esophageal cancer	7.2e-05	0.000162	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—esophageal cancer	7.2e-05	0.000162	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—esophageal cancer	7.18e-05	0.000161	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—NOTCH1—esophageal cancer	6.97e-05	0.000157	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CREBBP—esophageal cancer	6.32e-05	0.000142	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.56e-05	0.000125	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CREBBP—esophageal cancer	4.92e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NOS3—esophageal cancer	4.4e-05	9.9e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—esophageal cancer	4.03e-05	9.06e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—esophageal cancer	3.75e-05	8.44e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—esophageal cancer	3.35e-05	7.53e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—esophageal cancer	2.48e-05	5.57e-05	CbGpPWpGaD
